Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9BXW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,502
Award facts
- Contract value 100% obligated
- $10,502.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,502.44 to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pens on December 22, 2025, with completion scheduled for December 23, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. As a prime vendor under the DLA's pharmaceutical supply chain, the company supplies a comprehensive range of medications and medical products, including specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Wegovy—a GLP-1 receptor agonist primarily indicated for weight management—reflects the expanding scope of pharmaceutical products available through federal healthcare systems. The company's federal contract portfolio demonstrates consistent competitively-awarded, firm fixed price arrangements with DLA, positioning it as a critical vendor for federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F9BXW?
SPE2DR26F9BXW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F9BXW worth?
The government has obligated $10,502 on SPE2DR26F9BXW.
Is contract SPE2DR26F9BXW an order under another contract?
Yes. SPE2DR26F9BXW is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BXW competed?
The extent of competition for SPE2DR26F9BXW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award